Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
about
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.Effect of Statin Use on Influenza Vaccine Effectiveness.Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in SpainComparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysisThe effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013.Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons.Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewLow 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesApplication of the screening method to monitor influenza vaccine effectiveness among the elderly in GermanySuboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations.Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus typeEffectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in KoreaThe Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and LiguriaTrivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study.Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy.Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.A systematic review of the health economic consequences of quadrivalent influenza vaccination.A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment.2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China.2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
P2860
Q30383312-1D664BF3-BF48-404C-BB1F-EFF1264D2F78Q30391150-5A37CB2D-B0F9-4AF4-A0DE-6D44BC881E87Q30401497-2B693400-5CAE-4A68-8310-B3B09E46151FQ30403059-51F067A4-B184-473F-8980-D9745EB8BD9DQ30891396-552368D6-763C-4970-BE0A-7577256E70CDQ34194443-6C9538AA-B8FA-4131-B8BA-16DC3DDF7BA4Q34393525-6B95923D-AA5A-4D1E-8310-72135339DA92Q34505958-C51D8370-7709-4CD2-A335-1B15C06278F8Q34778408-D6E1B8E0-7A63-4430-9852-8C4ACB3D3D62Q35130915-931F2C0A-EEFD-455B-80F9-FC2F03AD6217Q35211657-826141B7-1F81-4810-AA1B-1EA7288FF1D2Q35225209-57E1BE21-4D8F-45D4-9598-EF6631200BEBQ35531934-30B7BEA2-A5BD-4B20-A75D-2418882403FAQ35758531-499F8243-E927-4800-827E-8C129FBBDF35Q36296560-83B770CE-3CD1-454C-BCAE-86AAE8BFE373Q36847186-3EF37733-D4F8-45B9-92B6-547B65BBCE1CQ37010796-1BCF1F08-F642-4C23-BA9D-2A81DCA6FE0CQ37568360-7BE65323-1394-4591-ADE9-E2737F609B7FQ37669436-C47ECFD5-1A79-41B3-A949-5AD25ABF7385Q38415770-8D404469-00C8-423A-8093-EC7571C4DC3EQ38639994-ED09437D-DE92-416D-8060-73ADDFCA606EQ38660898-EA1039EE-FEAD-437B-9352-595A9BF7237EQ38671179-22687966-4869-432D-856A-8046E82310ABQ38692107-E70F16AD-B706-42A1-924B-EC0BDA44ED9BQ39215322-C91EC1F1-954B-4D0C-BCEE-D74553370C8FQ39322780-81597FD9-203B-43F0-8C0F-B530CD30FFC5Q39340731-C69D1CE6-A4EB-4878-840F-4B3B1087183FQ39813068-124EF782-473D-49F0-8931-B2D48C644103Q39833076-80DE13AF-923F-4E5A-9DE5-EC612EA7C67AQ40087098-4CF92DCB-6090-42CC-9332-DAD06F37B450Q40143693-FBBD8435-36BD-422D-9890-17C38A64BAE2Q40374569-0E1C97B1-068D-410D-8422-D63697174019Q41932605-C97EFED1-5AAB-4639-9156-A8ECA0804E68Q41932798-D10BFB98-640F-4F73-A723-34CD56150433Q47137946-30148C75-C18A-4DA7-9AF7-030A51D22E95Q47160827-ACFE391A-3065-45BE-8BD1-66B19BF9B42EQ47229285-16475D39-BC6E-48CD-ADB4-B30DA34ABBCDQ47583920-DB1E8340-707E-4479-8B10-9C947031B04EQ47613621-7471E8BD-4021-49CF-8A55-A2BFA9ADD74BQ47678684-91F1A8B3-5D80-4AFE-BAF3-04808FAFF4FB
P2860
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@en
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@nl
type
label
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@en
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@nl
prefLabel
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@en
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@nl
P2093
P2860
P50
P356
P1476
Influenza A/subtype and B/line ...... ection with unchanged vaccine.
@en
P2093
Anne-Luise Winter
Danuta M Skowronski
Kevin Fonseca
Martin Petric
Paul Van Caeseele
Suzana Sabaiduc
Trijntje L Kwindt
P2860
P304
P356
10.1093/INFDIS/JIU048
P407
P50
P577
2014-01-19T00:00:00Z